NCT01506934View on ClinicalTrials.gov

A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Food Effect on Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors

PHASE1TerminatedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

January 31, 2012

Conditions
Advanced or Metastatic Solid Tumors
Interventions
DRUG

linifanib

"Single Dose on Day 1 of Periods 1, 2 and 3 (Bioavailability Portion)~Single Dose on Day 1 of Periods 1 and 2 (Food Effect Portion)"

Trial Locations (4)

21231

Site Reference ID/Investigator# 51465, Baltimore

48201

Site Reference ID/Investigator# 61282, Detroit

78229

Site Reference ID/Investigator# 52122, San Antonio

03756-0001

Site Reference ID/Investigator# 51463, Lebanon

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY